Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced the nomination of its 21st pre-clinical candidate, ISM8969, an …
Xaira Therapeutics, an integrated biotechnology company focused on leveraging AI to transform drug discovery and development, announced two key appointments …
Relation Therapeutics announced two strategic collaborations with GSK aimed at advancing drug discovery for fibrotic diseases and osteoarthritis, debilitating conditions …
Citryll, a biotechnology company focused on developing monoclonal antibody therapies to address immune-mediated inflammatory diseases, has completed an €85 million …
Inflammatory Bowel Disease (IBD), a chronic and debilitating autoimmune disorder that includes ulcerative colitis and Crohn’s disease, impacts millions of …
Dot Compliance, a provider of AI-powered compliance and electronic quality management system (eQMS) solutions, has introduced the third generation of …
Artificial intelligence (AI) is revolutionizing healthcare by enhancing workflows, enabling earlier diagnoses, and paving the way for personalized care. However, …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.
